Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

PPD expands central lab services to China

PPD : 24 January, 2008  (New Product)
PPD has expanded the company’s global central lab services into China by signing an exclusive agreement with Peking Union Lawke Biomedical Development (PUL).
The agreement allows PPD to begin immediately providing biopharmaceutical clients with its full range of highly customised central lab services in China.

'Chinese law makes it extremely difficult to export lab samples to other countries for testing,' said Agostino L Fede, PhD, senior vice president of PPD and head of PPD's global central labs. 'Our agreement with PUL expands our global central lab capabilities in a high growth clinical research market. It also saves our clients time and money by providing lab results more quickly without incurring expenses for exporting shipments.'

Under the terms of the agreement, PPD invested in laboratory equipment located at Peking Union Medical College in the Beijing Zhong Guan Cun Life Sciences Park, the largest life sciences park in China. The equipment is identical to platforms located at PPD's global central labs in Brussels, Belgium, and Highland Heights, Kentucky, USA, and assays performed have been extensively cross validated and precisely calibrated to match instruments at these labs. With these and other ongoing quality assurance measures, PUL and PPD deliver laboratory data that are directly combinable. In addition, PUL is interfaced real-time to ConneXion, PPD's proprietary computer system, to assure consistent management and reporting.

Jian Ho, MD, PhD, medical director at PUL, will oversee the lab while PPD will lead project management and investigator services and work with clients on study set up. As part of the agreement, PUL will conduct chemistry, haematology, urinalysis and haemoglobin A1c tests to support PPD's clinical trials business in China. PUL also offers an extensive range of esoteric tests. In return, PUL will have rights to use the equipment to conduct central lab testing for Chinese clients running clinical trials in China.

'PUL provides reference testing services to hospitals, clinics and is the largest reference lab in Beijing,' said Dr Ho. 'We are pleased to use our experience across numerous lab platforms to support PPD's global central labs.'

The PUL global central lab participates in the College of American Pathologists (CAP) external proficiency testing programme and has applied for CAP accreditation. PUL is performing National Glycohemoglobin Standards Program testing in anticipation of accreditation.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo